-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UXpL7KCT4fGR/e5UJHuZavKjlVGrD3aJoM12SKv49LOwybBHBlfDIibZVnWMoS3r 6qssOSJ/IhIrb8fgGsoMBw== 0000950134-03-014518.txt : 20031106 0000950134-03-014518.hdr.sgml : 20031106 20031106113913 ACCESSION NUMBER: 0000950134-03-014518 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20031106 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20031106 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNOVIS LIFE TECHNOLOGIES INC CENTRAL INDEX KEY: 0000780127 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 411526554 STATE OF INCORPORATION: MN FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-13907 FILM NUMBER: 03981401 BUSINESS ADDRESS: STREET 1: 2575 UNIVERSITY AVENUE CITY: ST PAUL STATE: MN ZIP: 55114-1024 BUSINESS PHONE: 6516033700 FORMER COMPANY: FORMER CONFORMED NAME: BIO VASCULAR INC DATE OF NAME CHANGE: 19920703 8-K 1 c80738e8vk.txt FORM 8-K - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 - -------------------------------------------------------------------------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 6, 2003 SYNOVIS LIFE TECHNOLOGIES, INC. (Exact name of Registrant as specified in its charter) State of Incorporation: Minnesota I.R.S. Employer Identification No.: 41-1526554 Address of principal executive offices: 2575 University Ave. W. St. Paul, Minnesota 55114 Telephone Number: (651) 603-3700 --------------------------------------------------- Item 5. Other Events and Regulation FD Disclosure. On November 6, 2003, Synovis Life Technologies, Inc. (Synovis) issued a press release announcing the promotion of Fariborz Boor Boor to executive vice president. A copy of the press release is attached hereto as Exhibit 99.1. Synovis will also publish the press release, including the supplemental information contained therein, on its website www.synovislife.com. Item 7. Financial Statements and Exhibits. (c) Exhibits. (99.1) Synovis Life Technologies, Inc. News Release dated November 6, 2003. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SYNOVIS LIFE TECHNOLOGIES, INC. By: /s/ Connie L. Magnuson ------------------------------ November 6, 2003 Connie L. Magnuson Vice-President of Finance and Chief Financial Officer 2 EX-99.1 3 c80738exv99w1.txt NEWS RELEASE EXHIBIT 99.1 FROM: FOR: Padilla Speer Beardsley Inc. Synovis Life Technologies, Inc. 1101 West River Parkway 2575 University Ave. Minneapolis, Minn. 55415 St. Paul, Minn. 55114 CONTACT: CONTACT: Nancy A. Johnson/Marian Briggs Karen Gilles Larson, President and CEO (612)455-1745/ (612)455-1742 Connie L. Magnuson, CFO njohnson@psbpr.com/ (651) 603-3700 mbriggs@psbpr.com FOR IMMEDIATE RELEASE SYNOVIS LIFE TECHNOLOGIES PROMOTES FARIBORZ BOOR BOOR TO EXECUTIVE VICE PRESIDENT ST. PAUL, Minn., November 6, 2003 -- Synovis Life Technologies (NASDAQ: SYNO), has promoted Fariborz Boor Boor, age 45, to executive vice president, effective immediately. He has served as president and chief operating officer of Synovis Interventional Solutions, a wholly owned subsidiary, since 2000 and joined the company in 1998. In his new position, the interventional business management will report to Boor Boor and he will build his involvement with Synovis' surgical business. "It is with great pleasure that we announce Fariborz' promotion," said Karen Gilles Larson, Synovis Life Technologies president and chief executive officer. "Under Fariborz' leadership, our interventional business has grown spectacularly, to $24.0 million for the first nine months of fiscal 2003 from $8.8 million for all of fiscal 2000. He has motivated his team to provide customers with best-in-class engineering services, project management and quality high-volume manufacturing. As a result, the interventional business has a strong and growing customer base." Boor Boor has more than 25 years of production management experience. Prior to joining Synovis, he served as quality assurance manager at Plastech Corporation in Rush City, Minn., and as division services manager at Phillips Plastics Corporation in Chippewa Falls, (more) Synovis Life Technologies November 6, 2003 Page 2 Wis. Boor Boor holds a bachelor's degree in chemistry and business administration from the University of Wisconsin at Eau Claire. ABOUT SYNOVIS LIFE TECHNOLOGIES Synovis Life Technologies, Inc., based in St. Paul, Minn., is a diversified medical device company engaged in developing, designing, manufacturing and bringing to market medical devices for the surgical and interventional treatment of disease. For additional information on Synovis Life Technologies and its businesses, visit the company's Web site at www.synovislife.com. Forward-looking statements contained in this press release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The statements can be identified by words such as "should", "may", "will", "expect", "believe", "anticipate", "estimate", "continue", or other similar expressions. Certain important factors that could cause results to differ materially from those anticipated by the forward-looking statements made herein include the timing of product introductions, the number of certain surgical procedures performed and the level of orders from contract manufacturing customers. A full discussion of factors can be found in the company's Annual Report on Form 10-K for the year ended October 31, 2002. # # # -----END PRIVACY-ENHANCED MESSAGE-----